Related Experiment Video
Updated: Aug 5, 2026

06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Recent Advances in Multimodal Assessment Scoring Systems for Prostate Cancer: An Integrated Pathological and Imaging
1Department of Radiology, Affiliated Hainan Hospital of Hainan Medical University, Haikou 571199, China.
Diagnostics (Basel, Switzerland)
|July 28, 2026
Summary
Accurate prostate cancer risk stratification relies on scoring systems like Gleason and PI-RADS. Integrating pathology and imaging data, such as PSMA-PET, offers improved precision for personalized treatment and patient outcomes.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Prostate cancer risk stratification relies on pathological scoring systems (Gleason, ISUP grade groups) but faces limitations like sampling bias.
- Multiparametric MRI (mpMRI) based PI-RADS scoring aids detection but suffers from inter-observer variability.
- Emerging PSMA-PET imaging scoring systems (PSMA-RADS, miTNM) offer advanced staging capabilities.
Purpose of the Study:
- To review current prostate cancer scoring systems.
- To highlight the limitations of existing pathological and imaging-based stratification methods.
- To explore the integration of multimodal data for enhanced predictive modeling.
Main Methods:
- Review of pathological scoring systems (Gleason, ISUP).
- Evaluation of imaging scoring systems (PI-RADS, PSMA-PET based systems).
- Discussion of multimodal data integration strategies.
Main Results:
- Pathological and current imaging systems have inherent limitations affecting risk stratification accuracy.
- Multimodal approaches integrating pathology and imaging show promise for overcoming single-modality shortcomings.
- Advanced imaging and integrated models aim for more personalized risk assessment.
Conclusions:
- Combining pathological and multimodal imaging data is crucial for comprehensive prostate cancer risk stratification.
- Integrated predictive models can address limitations of individual assessment methods.
- This approach optimizes treatment decisions and improves patient prognosis.
